Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Loren K. Tschetter"'
Autor:
Tom R. Fitch, Steven R. Alberts, Bradley S. Lair, Aminah Jatoi, Frank Nichols, Howard L. McLeod, Nathan R. Foster, Loren K. Tschetter, James A. Martenson, Dennis F. Moore
Publikováno v:
American Journal of Clinical Oncology. 30:507-513
Locally advanced esophageal cancer is challenging to treat. This study tested a 3-drug, multimodality approach. Chemotherapy dose reductions, the addition of amifostine, and pharmacogenetics were tested in an effort to mitigate toxicity and predict o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a41689c455bb7e84dafe6b7a82a76fd9
https://doi.org/10.1097/coc.0b013e31805c139a
https://doi.org/10.1097/coc.0b013e31805c139a
Autor:
Nguyet A. Le-Lindqwister, Richard D. Hurt, Gary A. Croghan, Charles L. Loprinzi, Stewart C. Garneau, Albert M. Bernath, Donald B. Wender, Shaker R. Dakhil, Kathleen A. Flynn, Kendrith M. Rowland, Paul J. Novotny, Jeff A. Sloan, Loren K. Tschetter, Ivana T. Croghan, Mary L. Loots, Larry P. Ebbert
Publikováno v:
Mayo Clinic Proceedings. 82:186-195
To compare the combination of a nicotine inhaler and bupropion to either treatment alone for initiating smoking abstinence and relapse prevention.Smokers were randomized to receive a nicotine inhaler, bupropion, or both for 3 months. At 3 months, smo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1b7f53a910670eead24bf00109b945
https://doi.org/10.1016/s0025-6196(11)60997-x
https://doi.org/10.1016/s0025-6196(11)60997-x
Autor:
Philip J. Stella, Paul J. Novotny, Jeff A. Sloan, Albert M. Bernath, Loren K. Tschetter, Gary A. Croghan, Sachdex P. Thomas, Matthew M. Clark, Stewart C. Garneau, Ivana T. Croghan, Larry P. Ebbert, Christi A. Patten, Donald B. Wender, Edward J. Wos, Shaker R. Dakhil, Roscoe F. Morton, Richard D. Hurt, Charles L. Loprinzi, Kendrith M. Rowland
Publikováno v:
Addictive Behaviors. 31:1144-1152
Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of sma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13f758dd06ccb535f018579bb79025b1
https://doi.org/10.1016/j.addbeh.2005.08.011
https://doi.org/10.1016/j.addbeh.2005.08.011
Autor:
Tom R. Fitch, David L. Graham, Shauna Hillman, Paul L. Schaefer, Homayoon Shahidi, Donald W. Northfelt, Loren K. Tschetter, William L. McGinnis, Yolanda I. Garces, Steven E. Schild, Alex A. Adjei, James R. Jett
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 65:1106-1111
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of radiation that can be administered with carboplatin and paclitaxel. Methods and Materials: This trial included 15 patients with unresectable non–small-cell lung canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f253c1cbc7774ec099e9e422ca80a727
https://doi.org/10.1016/j.ijrobp.2006.02.046
https://doi.org/10.1016/j.ijrobp.2006.02.046
Autor:
Tom R. Fitch, Preston D. Steen, Charles Erlichman, Kendrith M. Rowland, Suresh G. Nair Md, Loren K. Tschetter, Mark A. Schroeder, Nathan R. Foster, Steven R. Alberts, Dennis F. Moore
Publikováno v:
Journal of Clinical Oncology. 22:4944-4950
Purpose Gemcitabine remains the standard therapy for metastatic pancreatic adenocarcinoma (ACA), but has limited activity. ISIS-2503 is an antisense compound directed against H-ras with preclinical activity against pancreatic ACA in tumor models. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b28e31950d3e22af1706bb356484a8
https://doi.org/10.1200/jco.2004.05.034
https://doi.org/10.1200/jco.2004.05.034
Autor:
Lawerence Burgart, Patrick J. Flynn, Peter J. Cera, Michelle R. Mahoney, Hani Al-Khatib, Tom R. Finch, Harold E. Windschitl, Loren K. Tschetter, Ralph Levitt, James A. Knost, Steven R. Alberts
Publikováno v:
Cancer. 103:111-118
BACKGROUND Gemcitabine has broad activity in a variety of solid tumors including biliary tract carcinomas. The authors evaluated 6-month survival, response, and toxicity associated with a combination of gemcitabine, 5-fluorouracil (5-FU), and leucovo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d1cd122f07e901a3ee06cf83f123f2
https://doi.org/10.1002/cncr.20753
https://doi.org/10.1002/cncr.20753
Autor:
Robert D. Niedringhaus, Shauna Hillman, Jeff A. Sloan, James E. Krook, Susan Geyer, Gerardo Colon-Otero, Loren K. Tschetter, Martin Wiesenfeld, James J. Jett, Harold E. Windschitl, Randolph S. Marks
Publikováno v:
American Journal of Clinical Oncology. 24:551-555
Edatrexate is an antifolate agent with improved in vitro antineoplastic activity as compared with methotrexate. A Mayo phase I trial of edatrexate (E), vinblastine (V), doxorubicin (Adriamycin) (A), cisplatin (C), and filgrastim (GCSF), (EVAC-GCSF) s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327ada1a69f3cd6459bb395166a72ce2
https://doi.org/10.1097/00000421-200112000-00004
https://doi.org/10.1097/00000421-200112000-00004
Autor:
Delfino Vargas-Chanes, Martin Wiesenfeld, Paul L. Schaefer, Loren K. Tschetter, Paul J. Novotny, Charles L. Loprinzi, Maria Tria Tirona, Michael J. O'Connell, A K Hatfield, John A. Laurine, John W. Kugler, Jeff A. Sloan, Carl G. Kardinal, James E. Krook
Publikováno v:
Journal of Clinical Oncology. 19:3539-3546
PURPOSE: This article summarizes the third step of a research program to identify variables that supplement the predictive power of the the Eastern Cooperative Oncology Group (ECOG) performance status (PS) for survival. The objective was to produce a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e55b52fa688cc2d5a8a8c20439a9691
https://doi.org/10.1200/jco.2001.19.15.3539
https://doi.org/10.1200/jco.2001.19.15.3539
Autor:
G. H. Farr, J. A. Jefferies, Vera J. Suman, Loren K. Tschetter, Nancy E Fay, Roscoe F. Morton, Alan K. Hatfield, Thomas A. Gaffey, Lynn C. Hartmann, Bobbie S. Gostout, Samir Abu-Ghazaleh, Mary M. Gallenberg
Publikováno v:
International Journal of Gynecology & Obstetrics. 74:207-210
This paper presents a randomized clinical trial of standard local ablative treatment with and without systemic interferon-alpha for cervical dysplasia. To determine the extent of the lesion study participants underwent colposcopic examination and loc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16c5258d6b0deb891d397df00f0fb3c
https://doi.org/10.1016/s0020-7292(00)00389-1
https://doi.org/10.1016/s0020-7292(00)00389-1
Autor:
Sandra M. Smith, David W. Kimmel, Bernd W. Scheithauer, Paul L. Schaefer, Jan C. Buckner, Roscoe F. Morton, Robert B. Jenkins, Ralph Levitt, Eunice M. Hill, Michelle R. Mahoney, Arie Perry, James Krook, Thomas J. Sebo, Judith R. O'Fallon, Loren K. Tschetter
Publikováno v:
Cancer. 86:672-683
BACKGROUND The biologic behavior of anaplastic (World Health Organization Grade III) astrocytomas and oligoastrocytomas is highly variable, ranging from rapid progression to prolonged survival. It is difficult to predict the outcome of an individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fe4a7aedf6efd828968613a58360550
https://doi.org/10.1002/(sici)1097-0142(19990815)86:4<672::aid-cncr17>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19990815)86:4<672::aid-cncr17>3.0.co